SpyGlass Pharma, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Assets | |||
| Cash & Equivalents | $96.4M | $16.3M | $15.8M |
| Accounts Receivable | — | — | — |
| Inventory | — | — | — |
| Total Current Assets | $108.8M | $17.4M | — |
| Property, Plant & Equipment | $2.3M | $2.2M | — |
| Goodwill | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — |
| Total Assets | $115.9M | $23.3M | — |
| Liabilities | |||
| Accounts Payable | $2.7M | $2.0M | — |
| Total Current Liabilities | $8.6M | $7.8M | — |
| Long-Term Debt | — | — | — |
| Total Liabilities | $10.2M | $11.2M | — |
| Stockholders' Equity | |||
| Retained Earnings | $-104.7M | $-64.9M | — |
| Total Stockholders' Equity | $-98.8M | $-60.5M | $-33.0M |